Skip to content
healthcare.dev

ZONISADE

NDC 52652-8001, ZONISAMIDE, suspension, from Azurity Pharmaceuticals, Inc..

Product NDC
52652-8001
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214273
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52652-8001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZONISAMIDE100 mg/5mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; P-Glycoprotein Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
52652-8001-1526528001011 BOTTLE in 1 CARTON (52652-8001-1) / 150 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac16fa15-32e9-4f92-8bc6-d8d41ae002c6
  • NADAC price for package 52652800101

    GET /v1/drugs/nadac/52652800101

Use it

Look up 52652-8001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52652-8001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52652-8001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.